Finance

Novavax Jumps as Japan to Buy 150 million Doses of Covid Vaccine



© Reuters

By Dhirendra Tripathi

Investing.com – Novavax stock (NASDAQ:) climbed more than 6% Tuesday as Takeda Pharmaceutical (NYSE:) said the Japanese government will purchase 150 million doses of the Covid-19 vaccine it will produce using the American company’s formula.

Japan’s biggest drugmaker will make 250 million doses of the vaccine domestically and distribute it in early 2022, pending approval from regulators, according to a company statement today and previous announcements.

Novavax is licensing and transferring manufacturing technologies to enable Takeda to manufacture the vaccine, according to the statement.

Takeda is also distributing imported Moderna (NASDAQ:) vaccines in Japan. It plans to import 50 million doses of those shots.

Almost two weeks ago, the discovery of fragments of stainless steel some batches led to the suspension of as many as 2.6 million doses of Moderna’s ‘messenger RNA’-based vaccine in Japan. So far, three people have died in Japan after taking Moderna doses though the actual cause of the deaths is yet to be ascertained. The vaccines were found to be from the suspended batches.

The world’s third largest economy is battling its worst wave of the pandemic.

After a slow start, 58% of the population has now received at least one dose, according to a Reuters tracker.

 

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.





READ SOURCE

Leave a Reply

This website uses cookies. By continuing to use this site, you accept our use of cookies.